Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome

Behavioural Pharmacology

Volumn 10, Issue 5, 1999, Pages 467-474

  Allen, Samuel M ^a   Davis, W M ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

5,7 Dihydroxytryptamine; 6 Hydroxydopamine; Dopamine; m chlorophenylpiperazine; Mianserin; Rat; SCH 23390; Self mutilation; Serotonin; SKF 38393

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 5,7 DIHYDROXYTRYPTAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; MIANSERIN; OXIDOPAMINE; SEROTONIN; SEROTONIN 2C RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMUTILATION; BITE; CONTROLLED STUDY; FEMALE; HEAD MOVEMENT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LESCH NYHAN SYNDROME; MALE; NEOSTRIATUM; NEWBORN; NONHUMAN; RAT; STEREOTYPY;

EID: 0032820960     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199909000-00005     Document Type: Article

References (25)

1. Berger TW, Kaul S, Stricker EM, Zigmond MJ (1985). Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res 336:354-358.
2. Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Mueller RA (1984). Neonatal-6-hydroxydopamine treatment: Model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome. Pharmacol Biochem Behav 21:459-461.
3. Breese GR, Baumeister AA, Napier TC, Frye GD, Mueller RA (1985a). Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylatanine in rats treated neonatally with 6-hydroxydopamine. J Pharmacol Exp Ther 235:287-295.
4. Breese GR, Napier TC, Mueller RA (1985b). Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: Functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. J Pharmacol Exp Ther 234:447-455.
5. 2 dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J Pharmacol Exp Ther 240:167-176.
6. Breese GR, Criswell HE, Duncan GE, Mueller RA (1990). A dopamine deficiency model of Lesch-Nyhan disease - The neonatal-6-hydroxydopamine-lesioned rat. Brain Res Bull 25:477-484.
7. Brus R, Kostrzewa RM, Perry KW, Fuller RW (1994). Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J Pharmacol Exp Ther 268:231-237.
8. Criswell HE, Mueller RA, Breese GR (1989). Clozapine antagonism of D1 and D-2 dopamine receptor-mediated behaviors. Eur J Pharmacol 159:141-147.
9. Criswell HE, Mueller RA, Breese GR (1992). Pharmacological evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors. Neuropsychopharmacology 7:95-103.
10. Dray A, Gonye TJ, Oakley NR, Tanner T (1976). Evidence for the existence of a raphe projection to the substantia nigra in rat. Brain Res 113:45-57.
11. Ernst M, Zametkin AJ, Matochik JA et al. (1996). Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Eng J Med 334:1568-1572.
12. Giambalvo CT, Snodgrass SR (1978). Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: Comparison of injection sites. Brain Res 152:555-566.
13. Gong L, Kostrzewa RM, Fuller RW, Perry KW (1992). Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J Pharmacol Exp Ther 261:1000-1007.
14. Graybiel AM (1984). Neurochemically specified subsystems in the basal ganglia. In: Functions of the Basal Ganglia. Evered D, O'Connor M (editors). London: Pitman Publishing, pp. 114-149.
15. Gualtieri CT, Schroeder SR (1989). Pharmacotherapy for self-injurious behavior: Preliminary tests of the D1 hypothesis. Psychopharmacol Bull 25:364-371.
16. Kostrzewa RM (1995). Dopamine receptor supersensitivity. Neurosci Behav Rev 19:1-17.
17. Kostrzewa RM, Gong L, Brus R (1992). Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity. Acta Neurobiol Exp 53:31-41.
18. Kostrzewa RM, Brus R, Kalbfleisch J, Perry KW, Fuller RW (1994). Proposed animal model of attention deficit hyperactivity disorder. Brain Res Bull 34:161-167.
19. Lloyd KG, Hornykiewicz O, Davidson L et al. (1981). Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Eng J Med 305:1106-1111.
20. Luthman J, Friedemann M, Bickford P, Olson L, Hoffer BJ, Gerhardt GA (1993). In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment. Neuroscience 52:677-687.
21. Molina-Holgado E, Dewar KM, Descarries L, Reader TA (1994). Altered dopamine and serotonin metabolism in the dopamine denervated and serotonin hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J Pharmacol Exp Ther 270:713-721.
22. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates (2nd edn). San Diego, CA: Academic Press.
23. Plech A, Brus R, Kalbfleisch JH, Kostrzewa RM (1995). Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacology 119:466-473.
24. Stachowiak MK, Bruno JP, Snyder AM, Stricker EM, Zigmond MJ (1984). Apparent sprouting of striatal serotonergic terminals after dopamine depleting brain lesions in neonatal rats. Brain Res 291:164-167.
25. Towle AC, Criswell HE, Maynard EH et al. (1989). Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: An anatomical, biochemical and pharmacological study. Pharmacol Biochem Behav 34:367-374.